Report Code : CVMI2603252601436 | Published Date : March 30, 2025
nan





Reasons To Buy

nan




Scope

nan

Key Players

  • AstraZeneca
  • Bayer
  • Boehringer Ingelheim
  • Johnson & Johnson
  • GSK
  • Novartis
  • Fresenius Medical Care
  • Baxter
Global Chronic Kidney Disease Market Report

Global Chronic Kidney Disease Market Report


    1. Global Chronic Kidney Disease Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Global Chronic Kidney Disease Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
    2. Global Chronic Kidney Disease Market Research Report - Preface
    1. 2.1 Global Chronic Kidney Disease Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Treatment
      2. 2.1.2 By Drug Type
      3. 2.1.3 By End-User
      4. 2.1.4 By Distribution Channel
      5. 2.1.5 By Region
    3. Global Chronic Kidney Disease Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Treatment, By Drug Type, By End-User, By Distribution Channel, By Country
    3. 3.3. Opportunities – By Treatment, By Drug Type, By End-User, By Distribution Channel, By Country
    4. 3.4. Trends – By Treatment, By Drug Type, By End-User, By Distribution Channel, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Global Chronic Kidney Disease Market Research Report – DROTs Impact Analysis
    4. Global Chronic Kidney Disease Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. Global Chronic Kidney Disease Market, By Treatment, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Dialysis
      1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 5.2 Kidney Transplant
      1. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 5.3 Drug Therapy
      1. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Global Chronic Kidney Disease Market, By Drug Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 ACE Inhibitors
      1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 6.2 Angiotensin Receptor Blockers
      1. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 6.3 Diuretics
      1. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 6.4 Phosphate Binders
      1. 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. Global Chronic Kidney Disease Market, By End-User, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 Hospitals
      1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 7.2 Dialysis Centers
      1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 7.3 Clinics
      1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    8. Global Chronic Kidney Disease Market, By Distribution Channel, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 Hospital Pharmacies
      1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 8.2 Retail Pharmacies
      1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 8.3 Online Pharmacies
      1. 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    9. Global Chronic Kidney Disease Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 North America
      1. 9.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 9.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 9.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 9.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 9.2 Europe
      1. 9.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 9.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 9.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 9.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 9.3 Asia-Pacific
      1. 9.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 9.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 9.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 9.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 9.4 Latin America
      1. 9.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 9.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 9.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 9.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 9.5 Middle East & Africa
      1. 9.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 9.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 9.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 9.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 9.6 Global Chronic Kidney Disease Market - Opportunity Analysis Index, By Treatment, By Drug Type, By End-User, By Distribution Channel, and Region, 2024 - 2031
    10. North America Global Chronic Kidney Disease Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      10.1 By Treatment Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.1.1 Dialysis
      2. 10.1.2 Kidney Transplant
      3. 10.1.3 Drug Therapy
      10.2 By Drug Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.2.1 ACE Inhibitors
      2. 10.2.2 Angiotensin Receptor Blockers
      3. 10.2.3 Diuretics
      4. 10.2.4 Phosphate Binders
      10.3 By End-User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.3.1 Hospitals
      2. 10.3.2 Dialysis Centers
      3. 10.3.3 Clinics
      10.4 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.4.1 Hospital Pharmacies
      2. 10.4.2 Retail Pharmacies
      3. 10.4.3 Online Pharmacies
      10.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.5.1 United States
      2. 10.5.2 Canada
      10.6 North America Global Chronic Kidney Disease Market – Opportunity Analysis Index, By Treatment, By Drug Type, By End-User, By Distribution Channel, and Country, 2024 - 2031
      10.7 Regional Trends Analysis
      10.8 North America Global Chronic Kidney Disease Market Research Report - Company Profiles
      1. 10.8.1 Company 1 (United States)
      2. 10.8.2 Company 2 (Canada)
      3. 10.8.3 Company 3 (Canada)
    11. Europe Global Chronic Kidney Disease Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      11.1 By Treatment Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 Dialysis
      2. 11.1.2 Kidney Transplant
      3. 11.1.3 Drug Therapy
      11.2 By Drug Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 ACE Inhibitors
      2. 11.2.2 Angiotensin Receptor Blockers
      3. 11.2.3 Diuretics
      4. 11.2.4 Phosphate Binders
      11.3 By End-User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 Hospitals
      2. 11.3.2 Dialysis Centers
      3. 11.3.3 Clinics
      11.4 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.4.1 Hospital Pharmacies
      2. 11.4.2 Retail Pharmacies
      3. 11.4.3 Online Pharmacies
      11.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.5.1 Germany
      2. 11.5.2 United Kingdom
      3. 11.5.3 France
      4. 11.5.4 Spain
      5. 11.5.5 Italy
      6. 11.5.6 Russia
      7. 11.5.7 Netherlands
      8. 11.5.8 Poland
      9. 11.5.9 Rest of Europe
      11.6 Europe Global Chronic Kidney Disease Market – Opportunity Analysis Index, By Treatment, By Drug Type, By End-User, By Distribution Channel, and Country, 2024 - 2031
      11.7 Regional Trends Analysis
      11.8 Europe Global Chronic Kidney Disease Market Research Report - Company Profiles
      1. 11.8.1 Company 1 (Germany)
      2. 11.8.2 Company 2 (United Kingdom)
      3. 11.8.3 Company 3 (United Kingdom)
    12. Asia-Pacific Global Chronic Kidney Disease Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      12.1 By Treatment Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 Dialysis
      2. 12.1.2 Kidney Transplant
      3. 12.1.3 Drug Therapy
      12.2 By Drug Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 ACE Inhibitors
      2. 12.2.2 Angiotensin Receptor Blockers
      3. 12.2.3 Diuretics
      4. 12.2.4 Phosphate Binders
      12.3 By End-User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 Hospitals
      2. 12.3.2 Dialysis Centers
      3. 12.3.3 Clinics
      12.4 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.4.1 Hospital Pharmacies
      2. 12.4.2 Retail Pharmacies
      3. 12.4.3 Online Pharmacies
      12.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.5.1 China
      2. 12.5.2 Japan
      3. 12.5.3 India
      4. 12.5.4 South Korea
      5. 12.5.5 Australia & NZ
      6. 12.5.6 ASEAN
      7. 12.5.7 Rest of Asia-Pacific
      12.6 Asia-Pacific Global Chronic Kidney Disease Market – Opportunity Analysis Index, By Treatment, By Drug Type, By End-User, By Distribution Channel, and Country, 2024 - 2031
      12.7 Regional Trends Analysis
      12.8 Asia-Pacific Global Chronic Kidney Disease Market Research Report - Company Profiles
      1. 12.8.1 Company 1 (China)
      2. 12.8.2 Company 2 (Japan)
      3. 12.8.3 Company 3 (Japan)
    13. Latin America Global Chronic Kidney Disease Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      13.1 By Treatment Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.1.1 Dialysis
      2. 13.1.2 Kidney Transplant
      3. 13.1.3 Drug Therapy
      13.2 By Drug Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.2.1 ACE Inhibitors
      2. 13.2.2 Angiotensin Receptor Blockers
      3. 13.2.3 Diuretics
      4. 13.2.4 Phosphate Binders
      13.3 By End-User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.3.1 Hospitals
      2. 13.3.2 Dialysis Centers
      3. 13.3.3 Clinics
      13.4 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.4.1 Hospital Pharmacies
      2. 13.4.2 Retail Pharmacies
      3. 13.4.3 Online Pharmacies
      13.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.5.1 Brazil
      2. 13.5.2 Mexico
      3. 13.5.3 Argentina
      4. 13.5.4 Peru
      5. 13.5.5 Colombia
      6. 13.5.6 Rest of Latin America
      13.6 Latin America Global Chronic Kidney Disease Market – Opportunity Analysis Index, By Treatment, By Drug Type, By End-User, By Distribution Channel, and Country, 2024 - 2031
      13.7 Regional Trends Analysis
      13.8 Latin America Global Chronic Kidney Disease Market Research Report - Company Profiles
      1. 13.8.1 Company 1 (Brazil)
      2. 13.8.2 Company 2 (Mexico)
      3. 13.8.3 Company 3 (Mexico)
    14. Middle East & Africa Global Chronic Kidney Disease Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      14.1 By Treatment Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.1.1 Dialysis
      2. 14.1.2 Kidney Transplant
      3. 14.1.3 Drug Therapy
      14.2 By Drug Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.2.1 ACE Inhibitors
      2. 14.2.2 Angiotensin Receptor Blockers
      3. 14.2.3 Diuretics
      4. 14.2.4 Phosphate Binders
      14.3 By End-User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.3.1 Hospitals
      2. 14.3.2 Dialysis Centers
      3. 14.3.3 Clinics
      14.4 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.4.1 Hospital Pharmacies
      2. 14.4.2 Retail Pharmacies
      3. 14.4.3 Online Pharmacies
      14.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.5.1 Saudi Arabia
      2. 14.5.2 UAE
      3. 14.5.3 South Africa
      4. 14.5.4 Egypt
      5. 14.5.5 Israel
      6. 14.5.6 Rest of Middle East and Africa
      14.6 Middle East & Africa Global Chronic Kidney Disease Market – Opportunity Analysis Index, By Treatment, By Drug Type, By End-User, By Distribution Channel, and Country, 2024 - 2031
      14.7 Regional Trends Analysis
      14.8 Middle East & Africa Global Chronic Kidney Disease Market Research Report - Company Profiles
      1. 14.8.1 Company 1 (Saudi Arabia)
      2. 14.8.2 Company 2 (UAE)
      3. 14.8.3 Company 3 (UAE)
    15. Competition Landscape
      15.1 Strategic Dashboard of Top Market Players
      15.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 15.2.1 AstraZeneca
      2. 15.2.2 Bayer
      3. 15.2.3 Boehringer Ingelheim
      4. 15.2.4 Johnson & Johnson
      5. 15.2.5 GSK
      6. 15.2.6 Novartis
      7. 15.2.7 Fresenius Medical Care
      8. 15.2.8 Baxter
    16. Data Collection Method and Research Approach
    17. Principal Presumptions and Acronyms